Lung cancer surgery: An up to date

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.4, 2013, Pages

  Baltayiannis, Nikolaos ^a   Chandrinos, Michail ^a   Anagnostopoulos, Dimitrios ^a   Zarogoulidis, Paul ^b   Tsakiridis, Kosmas ^c   Mpakas, Andreas ^c   Machairiotis, Nikolaos ^d   Katsikogiannis, Nikolaos ^d   Kougioumtzi, Ioanna ^d   Courcoutsakis, Nikolaos ^d   Zarogoulidis, Konstantinos ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Saint Luke Private Hospital   (Greece)

^d UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

Author keywords

Lobectomy; Lung cancer; Non small cell lung cancer (NSCLC); Small cell lung cancer (SCLC); Staging; Surgery; Video assisted thoracoscopic surgery (VATS)

Indexed keywords

ADRENAL METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; DIAPHRAGM DISEASE; DISEASE SEVERITY; HUMAN; LOBECTOMY; LUNG CANCER; LUNG FUNCTION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; PATIENT SAFETY; PREOPERATIVE EVALUATION; RADIOSURGERY; REVIEW; RIB RESECTION; SEX DIFFERENCE; SURGICAL APPROACH; THORAX WALL DEFECT; TREATMENT INDICATION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84897497379     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.09.17     Document Type: Review

References (117)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010 15;127:2893-917.
2. Goldstraw P. eds. IASLC staging manual in thoracic oncology. FL: Editorial Rx Press, 2009.
3. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
4. Sobin LH, Gospodarowicz MK, Wittekind Ch. eds. International union against cancer, tnm classification of malignant tumours. 7th edition. Oxford: Wiley-Blackwell, 2010.
5. Edge SB, Byrd DR, Compton CC, et al. eds. American Joint Committee on Cancer, Cancer Staging Manual. 7th edition. Springer: New York, 2010:254-70.
6. Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer international staging project on lung cancer. J Thorac Oncol 2006;1:281-6.
7. Goodney PP, Lucas FL, Stukel TA, et al. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005;241:179-84.
8. Farjah F, Flum DR, Varghese TK Jr, et al. Surgeon specialty and longterm survival after pulmonary resection for lung cancer. Ann Thorac Surg 2009;87:995-1004; discussion 1005-6.
9. Ellis MC, Diggs BS, Vetto JT, et al. Intraoperative oncologic staging and outcomes for lung cancer resection vary by surgeon specialty. Ann Thorac Surg 2011;92:1958-63; discussion 1963-4.
10. von Meyenfeldt EM, Gooiker GA, van Gijn W, et al. The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol 2012;7:1170-8.
11. Ferraris VA, Saha SP, Davenport DL, et al. Thoracic surgery in the real world: does surgical specialty affect outcomes in patients having general thoracic operations? Ann Thorac Surg 2012;93:1041-7; discussion 1047-8.
12. Tieu B, Schipper P. Specialty matters in the treatment of lung cancer. Semin Thorac Cardiovasc Surg 2012;24:99-105.
13. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume onsurvival after resection for lung cancer. N Engl J Med 2001;345:181-8.
14. Meguid RA, Brooke BS, Chang DC, et al. Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg 2008;85:1015-24; discussion 1024-5.
15. Kozower BD, Stukenborg GJ. The relationship between hospital lung cancer resection volume and patient mortality risk. Ann Surg 2011;254:1032-7.
16. Dimick JB, Welch HG. The zero mortality paradox in surgery. J Am Coll Surg 2008;206:13-6.
17. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22; discussion 622-3.
18. Yan TD, Black D, Bannon PG, et al. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of videoassisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009;27:2553-62.
19. Paul S, Altorki NK, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010;139:366-78.
20. Park HS, Detterbeck FC, Boffa DJ, et al. Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg 2012;93:372-9.
21. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 2000;24:27-30; discussion 30-1.
22. De L Stanbridge R, Hon JK, Bateman E, et al. Minimally invasive anterior thoracotomy for routine lung cancer resection. Innovations (Phila) 2007;2:76-83.
23. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92.
24. Goldstraw P. Report on the international workshop on intrathoracic staging. Lung Cancer 1997;18:107-11.
25. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998;227:138-44.
26. Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) nonsmall cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662-70.
27. Takizawa H, Kondo K, Matsuoka H, et al. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer. J Med Invest 2008;55:37-43.
28. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-9; discussion 1019-20.
29. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
30. Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 nonsmall cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1990;49:242-6; discussion 246-7.
31. Jensik RJ, Faber LP, Milloy FJ, et al. Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg 1973;66:563-72.
32. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22; discussion 622-3.
33. Okada M, Koike T, Higashiyama M, et al. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-75.
34. Koike T, Yamato Y, Yoshiya K, et al. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8.
35. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006;82:408-15; discussion 415-6.
36. Kates M, Swanson S, Wisnivesky JP. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Chest 2011;139:491-6.
37. Wisnivesky JP, Henschke CI, Swanson S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 2010;251:550-4.
38. Kiser A. General aspects of surgical treatment. In: Detterbeck F, Rivera MP, Socinski MA, et al. eds. Diagnosis and treatment of lung cancer-an evidence based guide. Philadelphia: W B Saunders, 2001:177-90.
39. Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237-45.
40. Dominguez-Ventura A, Allen MS, Cassivi SD, et al. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg 2006;82:1175-9.
41. Sienel W, Dango S, Kirschbaum A, et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 2008;33:728-34.
42. Nakamura H, Taniguchi Y, Miwa K, et al. Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2011;59:137-41.
43. Kara M, Sak SD, Orhan D, et al. Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin? Lung Cancer 2000;30:161-8.
44. Tomaszek SC, Kim Y, Cassivi SD, et al. Bronchial resection margin length and clinical outcome in non-small cell lung cancer. Eur J Cardiothorac Surg 2011;40:1151-6.
45. Sawabata N, Ohta M, Matsumura A, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004;77:415-20.
46. El-Sherif A, Fernando HC, Santos R, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007;14:2400-5.
47. Stoelben E, Ludwig C. Chest wall resection for lung cancer: indications and techniques. Eur J Cardiothorac Surg 2009;35:450-6.
48. Magdeleinat P, Alifano M, Benbrahem C, et al. Surgical treatment of lungcancer invading the chest wall: results and prognostic factors. Ann Thorac Surg 2001;71:1094-9.
49. Sanli A, Onen A, Yücesoy K, et al. Surgical treatment in non-small cell lung cancer invading to the chest wall (T3) and vertebra (T4). Tuberk Toraks 2007;55:383-9.
50. Deslauriers J, Tronc F, Fortin D. Management of tumors involving the chest wall including pancoast tumors and tumors invading the spine. Thorac Surg Clin 2013;23:313-25.
51. Lee CY, Byun CS, Lee JG, et al. The prognostic factors of resected nonsmall cell lung cancer with chest wall invasion. World J Surg Oncol 2012;10:9.
52. Doddoli C, D'Journo B, Le Pimpec-Barthes F, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg 2005;80:2032-40.
53. Nakada T, Akiba T, Inagaki T, et al. A Rare Case of Primary Intercostal Leiomyoma: Complete Resection Followed by Reconstruction Using a Gore-Tex(®) Dual Mesh. Ann Thorac Cardiovasc Surg 2013. [Epub ahead of print].
54. Miller DL, Force SD, Pickens A, et al. Chest wall reconstruction using biomaterials. Ann Thorac Surg 2013;95:1050-6.
55. Berry MF, Onaitis MW, Tong BC, et al. Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection. Eur J Cardiothorac Surg 2012;41:888-92.
56. Cerfolio RJ, Bryant AS, Minnich DJ. Minimally invasive chest wall resection: sparing the overlying, uninvolved extrathoracic musculature of the chest. Ann Thorac Surg 2012;94:1744-7.
57. Burkhart HM, Allen MS, Nichols FC 3rd, et al. Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg 2002;123:670-5.
58. Weksler B, Bains M, Burt M, et al. Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg 1997;114:500-1.
59. Rocco G, Rendina EA, Meroni A, et al. Prognostic factors after surgical treatment of lung cancer invading the diaphragm. Ann Thorac Surg 1999;68:2065-8.
60. Yokoi K, Tsuchiya R, Mori T, et al. Results of surgical treatment of lung cancer involving the diaphragm. J Thorac Cardiovasc Surg 2000;120:799-805.
61. Lang-Lazdunski L. Surgery for nonsmall cell lung cancer. Eur Respir Rev 2013;22:382-404.
62. Kappers I, Belderbos JS, Burgers JA, et al. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients. Lung Cancer 2008;59:385-90.
63. Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008;26:644-9.
64. Yildizeli B, Dartevelle PG, Fadel E, et al. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Ann Thorac Surg 2008;86:1065-75; discussion 1074-5.
65. Demir A, Sayar A, Kocaturk CI, et al. Surgical treatment of superior sulcus tumors: results and prognostic factors. Thorac Cardiovasc Surg 2009;57:96-101.
66. Vos CG, Hartemink KJ, Blaauwgeers JL, et al. Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocol. Eur J Surg Oncol 2013;39:197-203.
67. Ripley RT, Rusch VW. Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy. Thorac Surg Clin 2013;23:273-85.
68. Goldstraw P, Mannam GC, Kaplan DK, et al. Surgical management of nonsmall-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994;107:19-27; discussion 27-8.
69. Cerfolio RJ, Bryant AS, Eloubeidi MA. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 2006;130:1791-5.
70. Al-Sarraf N, Aziz R, Gately K, et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 2008;33:104-9.
71. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-9; discussion 1019-20.
72. Rusch VW. Surgical Treatment of Patients With N2 Disease. Semin Radiat Oncol 1996;6:76-85.
73. Detterbeck F. What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 2008;3:289-302.
74. Detterbeck FC, Jones DR. Surgical treatment of stage IIIa (N2) nonsmall cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, et al. eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia, PA: W. B. Saunders, 2001:244-56.
75. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging nonsmall cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e211S-50S.
76. Burdett SS, Stewart LA, Rydzewska L. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. Cochrane Database Syst Rev 2007;(3):CD006157.
77. Gilligan D, Nicolson M, Smith I, et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 2007;369:1929-37.
78. VAN Schil PE, Waele MD, Hendrik JM, et al. Is there a role for surgery in stage IIIA-N2 non-small cell lung cancer? Zhongguo Fei Ai Za Zhi 2008;11:615-21.
79. Maher AR, Miake-Lye IM, Beroes JM, et al. Treatment of metastatic nonsmall cell lung cancer: a systematic review of comparative effectiveness and cost-effectiveness. Washington (DC): Department of Veterans Affairs (US); 2012 Oct. VA Evidence-based Synthesis Program Reports.
80. Sculier JP. Nonsmall cell lung cancer. Eur Respir Rev 2013;22:33-6.
81. Sørensen JB, Hansen HH, Hansen M, et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988;6:1474-80.
82. Read RC, Boop WC, Yoder G, et al. Management of nonsmall cell lung carcinoma with solitary brain metastasis. J Thorac Cardiovasc Surg 1989;98:884-90; discussion 890-1.
83. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
84. Burt M, Wronski M, Arbit E, et al. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. J Thorac Cardiovasc Surg 1992;103:399-410; discussion 410-1.
85. Trillet V., Catajar J.F., Croisile B., et al., Cerebral metastases as first symptom of bronchogenic carcinoma A prospective study of 37 cases. , Cancer ,1991, 67,2935-2940
86. Billing PS, Miller DL, Allen MS, et al. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001;122:548-53.
87. Hu C, Chang EL, Hassenbusch SJ 3rd, et al. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 2006;106:1998-2004.
88. Lo CK, Yu CH, Ma CC, et al. Surgical management of primary non-smallcell carcinoma of lung with synchronous solitary brain metastasis: local experience. Hong Kong Med J 2010;16:186-91.
89. Villarreal-Garza C, de la Mata D, Zavala DG, et al. Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases. Clin Lung Cancer 2013;14:6-13.
90. Porte HL, Roumilhac D, Graziana JP, et al. Adrenalectomy for a solitary adrenal metastasis from lung cancer. Ann Thorac Surg 1998;65:331-5.
91. Porte H, Siat J, Guibert B, et al. Resection of adrenal metastases from nonsmall cell lung cancer: a multicenter study. Ann Thorac Surg 2001;71:981-5.
92. Pfannschmidt J, Schlolaut B, Muley T, et al. Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer. Lung Cancer 2005;49:203-7.
93. Sebag F, Calzolari F, Harding J, et al. Isolated adrenal metastasis: the role of laparoscopic surgery. World J Surg 2006;30:888-92.
94. Mordant P, Arame A, De Dominicis F, et al. Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer? Eur J Cardiothorac Surg 2012;41:617-22.
95. Kozower BD, Larner JM, Detterbeck FC, et al. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e369S-99S.
96. Griffioen GH, Toguri D, Dahele M, et al. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors. Lung Cancer 2013. [Epub ahead of print].
97. Yu JB, Decker RH, Detterbeck FC, et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010;5:215-9.
98. Koizumi T, Fukushima T, Hamanaka K, et al. Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpydetected patients with others. World J Surg Oncol 2013;11:61.
99. Chandra V, Allen MS, Nichols FC 3rd, et al. The role of pulmonary resection in small cell lung cancer. Mayo Clin Proc 2006;81:619-24.
100. Lim E, Belcher E, Yap YK, et al. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008;3:1267-71.
101. Baltayiannis N, Bolanos N, Anagnostopoulos D, et al. Surgery in small cell lung cancer: when and why. J BUON 2005;10:459-72.
102. Inoue M, Sawabata N, Okumura M. Surgical intervention for smallcell lung cancer: what is the surgical role? Gen Thorac Cardiovasc Surg 2012;60:401-5.
103. Koletsis EN, Prokakis C, Karanikolas M, et al. Current role of surgery in small cell lung carcinoma. J Cardiothorac Surg 2009;4:30.
104. Ikeda N, Saji H, Hagiwara M, et al. Recent advances in video-assisted thoracoscopic surgery for lung cancer. Asian J Endosc Surg 2013;6:9-13.
105. McKenna RJ Jr. Lobectomy by video-assisted thoracic surgery with mediastinal node sampling for lung cancer. J Thorac Cardiovasc Surg 1994;107:879-81; discussion 881-2.
106. Kirby TJ, Rice TW. Thoracoscopic lobectomy. Ann Thorac Surg 1993;56:784-6.
107. Melfi FM, Menconi GF, Mariani AM, et al. Early experience with robotic technology for thoracoscopic surgery. Eur J Cardiothorac Surg 2002;21:864-8.
108. das-Neves-Pereira J.C., Riquet M., Le Pimpec-Barthes F., et al., Robotic Surgery for Lung Cancer, Robot Surgery, 2012, 172, 135-148, INTECH, Croatia, downloaded from SCIYO.COM In: Baik SH. eds
109. Hennon M, Sahai RK, Yendamuri S, et al. Safety of thoracoscopic lobectomy in locally advanced lung cancer. Ann Surg Oncol 2011;18:3732-6.
110. Merritt RE, Hoang CD, Shrager JB. Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer. Ann Thorac Surg 2013. [Epub ahead of print].
111. Toba H, Kondo K, Miyoshi T, et al. Fluoroscopy-assisted thoracoscopic resection after computed tomography-guided bronchoscopic metallic coil marking for small peripheral pulmonary lesions. Eur J Cardiothorac Surg 2013;44:e126-32.
112. Shen Y, Zhong M, Jiang W, et al. Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer. BMC Surg 2013;13:19.
113. Wang BY, Tu CC, Liu CY, et al. Single-incision thoracoscopic lobectomy and segmentectomy with radical lymph node dissection. Ann Thorac Surg 2013;96:977-82.
114. Hennon MW, Demmy TL. Thoracoscopic resection and re-resection of an anterior chest wall chondrosarcoma. Innovations (Phila) 2012;7:445-7.
115. Wu CY, Chen JS, Lin YS, et al. Feasibility and safety of nonintubated thoracoscopic lobectomy for geriatric lung cancer patients. Ann Thorac Surg 2013;95:405-11.
116. Oda M, Matsumoto I, Waseda R, et al. Total port-access lobectomy via a subcostal trans-diaphragmatic approach for lung cancer. Interact Cardiovasc Thorac Surg 2013;16:211-3.
117. Akiba T, Marushima H, Hirano K, et al. Thoracoscopic mediastinal lymph node dissection using an endoscopic spacer. Ann Thorac Cardiovasc Surg 2012;18:281-3